Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age15+
SponsorUniversity of Chicago
About this trial
This is a single center 2-phase study to assess effects of using text messages on adherence to oral chemotherapy for patients with acute lymphoblastic leukemia (ALL) or T-cell lymphoblastic lymphoma.
Eligibility criteria
Qualifiers
Age of 15 years or older at time of enrollment
Diagnosed with ALL or T-cell lymphoblastic lymphoma
Currently receiving treatment with pediatric-based regimen that includes maintenance with mercaptopurine and methotrexate (e.g., CALGB 10403). Study participation begins with the start of maintenance, so enrollment occurs prior to the start of maintenance. Patients in the pilot phase may have already started maintenance as long as the end of their maintenance therapy is scheduled to occur after the end of the 28-day pilot intervention.
Disqualifiers
Patient or caregiver who would receive text message reminders does not have a cell phone that receives text messages
Patient does not wish to participate
Text messages will be crafted in the patient's preferred language for medical communication, so English fluency is not an enrollment requirement.
Trial design
Treatments tested in this trial
- High Intensity
- No Text Messagings
- Low Intensity Text Messaging
Treatment groups
48 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov